MCP
ESLA icon

Maso Capital Partners’s Estrella Immunopharma ESLA Stock Holding History

Maso Capital Partners’s Portfolio ESLA Stock Details ESLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$11.5K Hold
10,000
– – 0.02% 36
2025
Q2 		$9.6K Hold
10,000
– – 0.02% 23
2025
Q1 		$9.27K Hold
10,000
– – 0.01% 27
2024
Q4 		$12K Hold
10,000
– – 0.02% 25
2024
Q3 		$11.6K Hold
10,000
– – 0.01% 25
2024
Q2 		$10.5K Hold
10,000
– – 0.01% 20
2024
Q1 		$12K Hold
10,000
– – 0.01% 28
2023
Q4 		$11K Hold
10,000
– – 0.01% 19
2023
Q3 		$93K Buy
+10,000
New +$101K 0.05% 28

Other funds holding ESLA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
ASM
ATW SPAC Management New York $79.2M AUM 10.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return